Testing effectiveness (Phase 2)Study completedNCT00219362
What this trial is testing
Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
Who this might be right for
HIV Infection
Objectif Recherche Vaccins SIDA 65